Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Figured this would happen, most of the upcoming catalyst have been terminated and management made no guarantees regarding investor allocation of the remaining cash.
I wouldn't count on it, management hasn't made any guarantees.
Aside from the remaining cash on hand, there are only 2 potential catalysts left here. And at this point I think management will say just about anything to keep the share price intact, so I wouldn't count on the remaining cash being distributed to shareholders any time soon. This may be a good time to Abandon ship m8's
RIP SNTA
http://stks.co/g48PT <--- Most recent 10-K (PDF format)
You still might get .15 idk why everybody is acting like positive data was just released.
From what I understand Galaxy 2 was a form of Ganetespib intended to target tumor cells on the glandular structures of the lungs and in this trial Ganetespib will be attempting to target tumor cells near the surface of the lungs. I'm not a pharmacist with extensive knowledge on the mechanism of action of Ganetespib but I just don't see how a drug with a similar profile of Galaxy 2 will suddenly be more effective against a similar type of cancer.
Alternately there are still 4+ trials remaining and
before the board crucifies me, I still think its inevitable we see some good news from at least one.
Apologies if some of that sounds pessimistic, but I like to think of the risk more than the reward.
If for some reason Ganetespib fails to meet its endpoints I wouldn't be surprised if we see .14-.16 after a panic induced selloff.
News of Ganetespib's effectiveness against malignant mesothelioma should be coming out this month, according to the link below.
https://clinicaltrials.gov/ct2/show/NCT01590160
.0004 up soon
Told you so ;)
Past tence? lol it appears the market doesn't agree
I suppose my English must be wrong. I don't recall saying "I told you so". Well, at least not yet lol
I understand your optimistic outlook however, it is inevitable that without meaningful news regarding what Slnn plans on doing differently in the future; this is destined for .000's. It's obvious that what they've been doing the last few years hasn't generated any profit, so something needs to change. JMHO
Gltu
I'd hate to say I told you so, but....
No surprise there, tell that to the people who chased after Slnn and bought in at .003
Mos Eisley, problem is they've only built 5 in the past 10 years lol
[img][/img]
I love it when people think they've got me all figured out based on one post. I may new to the message boards of I-hub, but I'm not a new investor. Since you're so experienced you should already know that most gains made in penny-land don't hold up very long unless significant news is released. You can ridicule me for speaking against a stock you bought, but that wont help you recoup your losses lol
Keep buying high and selling low
"Newb" out
Without a press release this is going right back down to the trips.
If nothing changes expect mid .20's by the end of the month
Called it :)
If you read nothing else from the 8k please read this.
"Pursuant to the LOI and the Senior Note, upon completion of the Qualified Offering at the Target Amount, the investors in the Qualified Offering will collectively beneficially own 60.9% of our company, the Existing Lenders will beneficially own 26.1% of our company (pursuant to the conversion of their notes into shares of Preferred Stock), Steve Saleen will beneficially own 10% of our company (excluding a warrant to purchase 5% of our outstanding shares of common stock), and all other stockholders will beneficially own approximately 3% of our company."
"In the event that the Company consummates a Qualified Offering, then the outstanding principal balance of this Note, together with any accrued and unpaid interest thereon, shall, at the option of the Holder, be converted into the Preferred Shares at a conversion price equal to the purchase price paid by the investors purchasing such Preferred Shares, consistent with capitalization of the Company set forth in the table in Section 3 e) below. The Company shall, as soon as practicable following the consummation of a Qualified Offering, deliver to the Holder notice thereof."
Glta
Wouldn't be surprised if Raytheon starts struggling after Obama leaves office. Hopefully the next president ins't dumb enough to arm Radical Terrorists with TOW missiles.
liveleak.com/view?i=91d_1449505200
I think we might see .35-.38 next week, if Snta manages to close below the .40 support.
Makes sense, my only concern is he knows something we don't about Ganetespib.
Do you think Bruce K. is selling to compensate the employees Snta laid off? & they certainly do, but at the moment I don't think they can say anything investors don't already know.
Wouldn't expect any significant gains here until the 2cnd half of 2016, until then I think we trade sideways give or take a few sporadic swings.
I'm New to Ihub. Was just curious as to what the colors of the volume bars indicate. I think the Blue are buys and the Red are sells, but what about Green? I've noticed some green volume bars in the volume graph for Synta pharmaceuticals today.
This is getting ugly. If management doesn't release an update soon this going to the low .30's
Makes sense, thanks for the insight
Anybody have an idea on what price Snta will bottom at?
So basically what just happened is the opposite of a short squeeze? I don't short sell so i wouldn't know
someone just unloaded 200k.
i'll buy in at .35
Anyone know where the RSI is currently at?
The pps isn't based on cash anymore but rather on investor confidence in the company's future.
This should be trading around $.64 (88,000,000 market cap/ 137,000,000 shares= .64pps)
IMO SNTA's debt may be starting to effect the PPS. I think the price is at the mercy of shorts and sporadic sell offs until good news comes out about ganetespib.
p.s. I Hope we dip below .50 before December; I need a nice entry :)